| By Business Wire |
Article Rating: |
|
| January 29, 2013 03:00 AM EST |
Reads: |
272 |
BIT C2 Diagnostics, a BIT company, has announced immediate expansion of
its 1400 square meter facility to include a Hematology Competence
Center. Construction of the 2.7 million Euro, 400 square meter expansion
is already complete and occupation of the new Center is expected by the
end of January, 2013. “We’re looking forward to having the space to work
on more projects simultaneously,” said Eric Jolain, CEO of BIT C2
Diagnostics. “We’ll also be able to ensure greater reliability at
product launch due to the fact that all production will now be done
internally, interfacing strictly with other BIT manufacturing sites –
such as BIT Analytical Instruments, GmbH and BIT MedTech in Irvine, CA,
USA.”
BIT C2 Diagnostics is a leader in development, design, manufacture and
support of custom Hematology instrumentation. With its comprehensive
technical expertise, BIT C2 Diagnostics is able to provide a large array
of engineering services, from rapid prototyping to OEM design and
manufacturing.
BIT C2 Diagnostics is a BIT company. For over 35 years BIT Group (http://www.BIT-Companies.com)
has provided services in the field of contract development and
manufacturing as well as after-sales service for customers in the fields
of medical, diagnostics, life science, and biotechnology. As a part of
the financially strong Messer Group, BIT Companies provide their systems
solutions worldwide and in compliance with ISO 13485 and 9001 standards.
As registered contract service providers to the FDA, BIT Companies meet
the stringent regulations with regard to medical and complex medical
technical products while simultaneously adhering to predefined
design-to-cost and time-to-market targets.
BIT Companies include BIT Medtech, Source Scientific, & BIT Analytical
Instruments Ltd. (USA) BIT Analytical Instruments GmbH (Germany); BIT
Technologies (China); BIT Japan (Japan); and BIT C2 Diagnostics (France).
